About Vimta
Vimta is a company based in Hyderabad (India) founded in 1984. The company has 1,310 employees as of March 31, 2024. Vimta offers products and services including cGMP Laboratory Service, Preclinical Research, Clinical Research, and Food Testing Services. Vimta operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Headquarter Hyderabad, India
- Employees 1310 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vimta Labs Limited
-
Annual Revenue
$40.27 M (USD)19.19as on Mar 31, 2025
-
Net Profit
$7.88 M (USD)64.21as on Mar 31, 2025
-
EBITDA
$14.4 M (USD)29.53as on Mar 31, 2025
-
Latest Funding Round
$17 M (USD), Post-IPO
Jun 01, 2006
-
Investors
-
Employee Count
1310
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Vimta
Vimta is a publicly listed company on the NSE with ticker symbol VIMTALABS in India, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Vimta
Vimta offers a comprehensive portfolio of products and services, including cGMP Laboratory Service, Preclinical Research, Clinical Research, and Food Testing Services.
Provides compliant testing for pharmaceutical products and safety
Conducts studies for drug development and efficacy testing
Offers trials for biologics and biosimilars evaluation
Ensures quality and safety in food and water analysis
People of Vimta
Unlock access to complete
Unlock access to complete
Funding Insights of Vimta
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $17.0M
-
First Round
First Round
(01 Jun 2006)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2006 | Amount | Post-IPO - Vimta | Valuation |
investors |
|
Investments & Acquisitions by Vimta
Financial Statements - Vimta
Vimta Comparisons
Competitors of Vimta
Vimta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of laboratory tests for physicians
|
|
| domain | founded_year | HQ Location |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| domain | founded_year | HQ Location |
Early drug development services are provided for pharma firms.
|
|
| domain | founded_year | HQ Location |
Cell line engineering services are offered via CRISPR-Cas9 technology.
|
Frequently Asked Questions about Vimta
Vimta was founded in 1984 and raised its 1st funding round 22 years after it was founded.
Vimta is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2024, the latest employee count at Vimta is 1,310.
Annual revenue of Vimta is $40.27M as on Mar 31, 2025.
Vimta Labs was founded in 1984 in Hyderabad, India, functioning as a contract research organization for pharmaceutical and biotechnology sectors. Analytical services, clinical research, preclinical studies, genomics, proteomics, and BABE testing are delivered to global clients. Operations involve 565 scientists working in chemistry, pharmacy, medicine, microbiology, molecular biology, and informatics.
Vimta's top competitors include LabCorp, Charles River Laboratories and Cytel.
Vimta offers cGMP Laboratory Service, Preclinical Research, Clinical Research, and Food Testing Services.
Yes, Vimta is publicly traded on NSE under the ticker symbol VIMTALABS.
The ticker symbol of Vimta is VIMTALABS on NSE.